Visa analysis: U.S. rings in holiday retail spending growth
This year, Visa’s preliminary insights indicate that the overall holiday retail spend in the U.S. increased 4.8% year over year.
This year, Visa’s preliminary insights indicate that the overall holiday retail spend in the U.S. increased 4.8% year over year.
$17M Series B round led by Aquiline to fuel Scripta’s growth into health plan and Medicare Advantage markets.
Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA.
PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.
The continuing resolution to fund the government failed a House vote, 235 to 174.
Clark designed two new basketballs for the Inspire Series – the Tribute and the Dreamer.
CRN cautions that misinterpretation of the recommendations as broadly advising against supplementation could lead to the dismissal of other health benefits associated with these essential nutrients.
Aims to drive progress against acute challenges facing children and youth.
But Congress must ignore big insurance and the PBM lobby’s last-ditch effort to scuttle reforms and pass the continuing resolution.
NACDS is hailing PBM reforms contained in the 118th Congress’ culminating legislative package, and is urging the U.S. House of Representatives and U.S. Senate to advance this continuing resolution to President Biden’s desk for signature.
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).
"Over half of consumers expect to complete their shopping in the week leading up to the Christmas holiday.”
The Advisory Committee's scientific report revealed troubling trends: Americans’ diets consistently fall short of aligning with Dietary Guidelines recommendations, leading to increased risk of nutrient inadequacies.
NACDS: “As the continuing resolution is finalized, Americans and their pharmacies are watching and waiting for real PBM reform now to lower drug costs and to protect pharmacy access”.
Coresight Research sees the retail sector as being at a critical juncture, where embracing innovation and adapting to changing consumer preferences are no longer optional but essential for survival.